GLEN BURNIE, Md., Jan. 17, 2017 /PRNewswire/ -- CSSi, the global leader in patient recruitment, enrollment and retention solutions for the clinical research industry, will exhibit at the 8th Annual SCOPE Summit for Clinical Trials Operations Executives (SCOPE 2017), taking place from Tuesday, January 24 - Thursday, January 26, 2017 at the Hyatt Regency Miami in Miami, FL.
At SCOPE 2017, CSSi will introduce its newest proprietary technology platform, SmartStudy™ EMR, which provides a revolutionary look into a site's EMR database. SmartStudy™ EMR will help to rapidly identifying protocol-specific patients within an investigative site's EMR. With a technology wrapped around services, we can save the site time and resources in identifying and contacting patients to speed up the enrollment process. CSSi will help Sponsors and CROs conduct thorough site feasibility allowing for selection of quality sites with potential patients pre-identified. This will save sponsors time and money by selecting the right sites.
"CSSi is pleased once again to be participating in the annual SCOPE Summit as an exhibitor, especially with this year's exciting announcement," says Chris Trizna, President, CSSi. "We are confident that SmartStudy™ EMR will transform the way investigative sites are selected and trials are enrolled. SCOPE 2017 will provide us with an invaluable learning experience and a chance to showcase our superb patient engagement capabilities and unique Local Enrollment Specialist™ services. We are looking forward to a successful event!"
Organized by Cambridge Healthtech Institute, SCOPE 2017 is a three-day event that will feature expert-led discussions in 13 different conferences, 6 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management. Areas of focus will include Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Lab Services, Precision Medicine and Biomarker-Driven Trials.
All Clinical Consulting Services companies, including CSSi, CSSi LifeSciences™ and Nexus Informatics, are committed to the development of disruptive approaches to bring clinical trials and improved care to patients.
CSSi will be exhibiting in booth 610 during the Summit. If you'd like arrange a meeting with CSSi personnel, please email email@example.com.
CSSi is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sponsors, CROs, SMOs and investigative sites. CSSi delivers global patient recruitment solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. The CSSi in-house patient recruitment and enrollment team brings years of patient recruitment knowledge across all disciplines: project management, creative development, direct-to-patient media planning and purchasing, and information-technology solutions. For more information on CSSi, visit www.CSSiEnroll.com, email firstname.lastname@example.org or call (866) 277-4888.
Facebook.com/CSSiEnroll – Twitter.com/@EnrollPatients – LinkedIn.com/CSSi - Global Patient Recruitment
PR & Marketing Coordinator
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cssi-to-exhibit-at-8th-annual-scope-summit-in-miami-fl-300391524.html